DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

H.C. Wainwright Initiates Coverage On Corvus Pharmaceuticals with Buy Rating, Announces $10 Price Target

H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy rating and a $10 price target.

Benzinga · 03/10/2020 11:29

H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy rating and a $10 price target.